Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 162
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Br J Dermatol ; 186(3): 508-519, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-34625951

RESUMEN

BACKGROUND: Postinflammatory hyperpigmentation (PIH) is a common, acquired pigmentary disorder of the skin associated with significant quality-of-life impairment, especially in individuals with skin of colour. Current treatment for PIH is limited, largely due to a poor understanding of disease pathogenesis and the lack of a representative disease model. OBJECTIVES: This study is intended to further develop, update and validate our previously designed in vivo model of acne-induced PIH/postinflammatory erythema (PIE) using different concentrations of trichloroacetic acid (TCA), a medium-depth chemical peel. METHODS: Twenty-nine patients with skin types II-VI and clinician-confirmed presence of two or more truncal acne pustules and PIH/PIE were included. On the basis of Investigator's Global Assessment (IGA), clinical polarized photography (CPP), colorimetry and Skindex, we experimentally determined an optimum TCA concentration and assessed our model's ability to exhibit a dose-response relationship between degree of inciting insult and severity of resulting pigmentation. We also performed differential microRNA profiling and pathway analysis to explore the potential of microRNAs as molecular adjuncts to our model. RESULTS: Application of TCA 30% produced lesions indistinguishable from acne-induced PIH and PIE lesions on the basis of colorimetry data without causing epidermal necrosis. Application of progressively increasing TCA doses from 20% to 30% resulted in concentration-dependent increases in CPP, IGA and colorimetry scores at all timepoints during the study. miRNA-31 and miRNA-23b may play a role in PIH pathogenesis, although further validation is required. CONCLUSIONS: Our TCA-based in vivo model, using TCA concentrations between 20% and 30% with an optimum of 30%, enables the quantitative assessment of the pigmentary response to varying degrees of cutaneous inflammation in a fashion that mirrors natural acne-induced PIH and PIE.


Asunto(s)
Acné Vulgar , Hiperpigmentación , MicroARNs , Acné Vulgar/complicaciones , Acné Vulgar/patología , Colorimetría , Eritema/etiología , Humanos , Hiperpigmentación/patología , Inmunoglobulina A , Ácido Tricloroacético
2.
Clin Exp Dermatol ; 47(4): 757-759, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-34798683

RESUMEN

The use of a broad-spectrum sunscreen remains an essential aspect of photoprotection. The environmental and health impacts attributed to certain ultraviolet filers have resulted in public confusion. Hence, the objective of this study is to explore public interest in sunscreen searches using Google Trends.


Asunto(s)
Motor de Búsqueda , Protectores Solares , Humanos , Protectores Solares/uso terapéutico , Rayos Ultravioleta/efectos adversos
3.
J Eur Acad Dermatol Venereol ; 35(7): 1460-1469, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-33764577

RESUMEN

Increasing evidence on the impact of the different wavelengths of sunlight on the skin demonstrates the need for tailored recommendations of sunscreen according to skin phototype and dermatoses, which is now possible due to advances in the filters and formulations of sunscreens. A selective literature search was performed by an international expert panel, focusing on the type of sunscreen to recommend for photoaging, skin cancers, photodermatoses, pigmentary disorders and skin inflammatory disorders. Protection against ultraviolet (UV)B is especially important for light skin as there is a high risk of sunburn, DNA damage and skin cancers. Darker skin may be naturally better protected against UVB but is more prone to hyperpigmentation induced by visible light (VL) and UVA. Protection against UVA, VL and infrared A can be helpful for all skin phototypes as they penetrate deeply and cause photoaging. Long-wave UVA1 plays a critical role in pigmentation, photoaging, skin cancer, DNA damage and photodermatoses. Adapting the formulation and texture of the sunscreen to the type of skin and dermatoses is also essential. Practical recommendations on the type of sunscreen to prescribe are provided to support the clinician in daily practice.


Asunto(s)
Neoplasias Cutáneas , Quemadura Solar , Humanos , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/prevención & control , Luz Solar , Protectores Solares/uso terapéutico , Rayos Ultravioleta/efectos adversos
4.
J Eur Acad Dermatol Venereol ; 34(3): 447-454, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31898355

RESUMEN

The use of sunscreens is an important and essential component of photoprotection. Since their introduction during the first half of the last century, sunscreens have benefited enormously from major technological advances such as the development of novel UV filters; as a result, their efficacy in preventing UV-induced erythema is unequivocal. More recently, however, new challenges have appeared, which have prompted a robust discussion about the safety of sunscreens. These include topics directly related to photoprotection of human skin such as improved/alternative methods for standardization of assessment of the efficacy of sunscreens, but also many others such as photoprotection beyond UV, concerns about human toxicity and ecological safety, the potential of oral photoprotective measures, consequences of innovative galenic formulations. On a first glance, some of these might raise questions and doubts among dermatologists, physicians and the general public about the use sunscreens as a means of photoprotection. This situation has prompted us to critically review such challenges, but also opportunities, based on existing scientific evidence. We conclude by providing our vision about how such challenges can be met best in the future in an attempt to create the ideal sunscreen, which should provide adequate and balanced protection and be easy and safe to use.


Asunto(s)
Eritema/prevención & control , Neoplasias Cutáneas/prevención & control , Protectores Solares/uso terapéutico , Eritema/etiología , Predicción , Humanos , Guías de Práctica Clínica como Asunto , Neoplasias Cutáneas/etiología , Rayos Ultravioleta/efectos adversos
5.
Br J Dermatol ; 180(3): 574-579, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30030843

RESUMEN

BACKGROUND: There is no cure or firm clinical recommendations for the treatment of vitiligo. One of the main issues is the heterogeneity of outcome measures used in randomized controlled trials for vitiligo. OBJECTIVES: To define successful repigmentation from the patients' point of view and to propose how and when repigmentation should be evaluated in clinical trials in vitiligo. METHODS: We conducted three workshops with patients with vitiligo and their parents or caregivers. Workshop 1 was held at World Vitiligo Day (Detroit, MI), workshop 2 at the University of Texas Southwestern Medical Center and workshop 3 at the Vitiligo and Pigmentation Institute of Southern California, University of California. RESULTS: Seventy-three participants were recruited. Consensus on the following questions was achieved unanimously: (i) the definition of 'successful repigmentation' was 80-100% of repigmentation of a target lesion and (ii) both an objective and a subjective scale to measure repigmentation should be used. CONCLUSIONS: This was the largest patients' outcomes workshop. We followed the guidance from the CSG-COUSIN and the Vitiligo Global Issues Consensus Group. Our recommendations to use percentage of repigmentation quartiles (0-25%, 26-50%, 51-79%, 80-100%) and the Vitiligo Noticeability Scale are based on the best available current evidence. A limitation of the research is that the workshops were conducted only in the U.S.A., due to pre-existing organisational support and the availability of funding.


Asunto(s)
Conferencias de Consenso como Asunto , Consenso , Satisfacción del Paciente , Pigmentación de la Piel , Vitíligo/terapia , Adolescente , Adulto , Ensayos Clínicos como Asunto , Color , Técnica Delphi , Femenino , Humanos , Masculino , Piel/diagnóstico por imagen , Resultado del Tratamiento , Estados Unidos , Vitíligo/diagnóstico
6.
J Eur Acad Dermatol Venereol ; 33 Suppl 1: 3-36, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30561009

RESUMEN

For many decades and until recently, medical approach to dermatologic diseases has been based on the physician's ability to recognize and treat symptoms. Nowadays, advances in the understanding of the biology of diseases and in technologies for intervening against them have allowed physicians to diagnose and treat underlying disease processes rather than simply addressing the symptoms. This means that rather than addressing 'the disease in humans', physicians can now address the particular pathologic (biologic, molecular) disturbance as it presents in the individual patient, i.e., physicians now can practice something much closer to 'personalized medicine', leading to greater benefits for the patients and the health of society in general. The deeper understanding of ultraviolet radiation, the importance of photoprotection and increased knowledge about signalling pathways of melanoma and carcinoma have led to more complete care for the dermatologic patient. The current popularity for excessive exposure to the sun, without adequate application of the appropriate photoprotection remedies, is the origin of melanoma, but also for the weakening of the structure and functions of the skin. Indeed, fragility of the skin can affect humans around the world. In the senior population, this skin fragility is accompanied by pruritus, whereas atopic dermatitis is an inflammatory disease with highest prevalence in children and adolescents. Acne, the number one reason for dermatologic consultations worldwide, increases its prevalence in adolescents and in females. Senescent alopecia affects humans after menopause and andropause. The articles in this publication present an overview of the current advanced understanding of the diagnosis and therapeutic approaches in 6 fields of dermatology - dermatopaediatry and gerontodermatology, oncodermatology, hair loss, atopic dermatitis, photoprotection and acne - and thereby serve as a useful compendium of updated information and references for all healthcare professionals who see patients with presentations of the symptoms of these diseases.


Asunto(s)
Acné Vulgar/tratamiento farmacológico , Alopecia/terapia , Dermatitis Atópica/tratamiento farmacológico , Dermatología/tendencias , Neoplasias Cutáneas/tratamiento farmacológico , Protectores Solares/química , Rayos Ultravioleta/efectos adversos , Acné Vulgar/complicaciones , Cicatriz/etiología , Cicatriz/terapia , Dermatitis Atópica/fisiopatología , Humanos , Inmunoterapia , Cumplimiento de la Medicación , Terapia Molecular Dirigida , Medicina de Precisión , Envejecimiento de la Piel , Neoplasias Cutáneas/terapia , Protectores Solares/efectos adversos
9.
J Digit Imaging ; 32(3): 478-488, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30238344

RESUMEN

In cone-beam computed tomography (CBCT), reconstructed images are inherently degraded, restricting its image performance, due mainly to imperfections in the imaging process resulting from detector resolution, noise, X-ray tube's focal spot, and reconstruction procedure as well. Thus, the recovery of CBCT images from their degraded version is essential for improving image quality. In this study, we investigated a compressed-sensing (CS)-based blind deconvolution method to solve the blurring problem in CBCT where both the image to be recovered and the blur kernel (or point-spread function) of the imaging system are simultaneously recursively identified. We implemented the proposed algorithm and performed a systematic simulation and experiment to demonstrate the feasibility of using the algorithm for image deblurring in dental CBCT. In the experiment, we used a commercially available dental CBCT system that consisted of an X-ray tube, which was operated at 90 kVp and 5 mA, and a CMOS flat-panel detector with a 200-µm pixel size. The image characteristics were quantitatively investigated in terms of the image intensity, the root-mean-square error, the contrast-to-noise ratio, and the noise power spectrum. The results indicate that our proposed method effectively reduced the image blur in dental CBCT, excluding repetitious measurement of the system's blur kernel.


Asunto(s)
Tomografía Computarizada de Haz Cónico , Compresión de Datos/métodos , Aumento de la Imagen/métodos , Procesamiento de Imagen Asistido por Computador/métodos , Radiografía Dental/métodos , Algoritmos , Diseño de Equipo , Humanos , Fantasmas de Imagen
10.
Br J Dermatol ; 178(5): 1173-1180, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-28877342

RESUMEN

BACKGROUND: Visible light (VL) induces multiple cutaneous effects. Sunscreen testing protocols recommended by regulatory bodies throughout the world require the use of solar simulators with spectral output in the ultraviolet (UV) domain only. However, sunlight contains VL and infrared radiation also. OBJECTIVES: This study aimed to evaluate the contributions of VL and UVA on pigmentation and erythema, and optimize parameters for in vivo testing. METHODS: Ten subjects with Fitzpatrick skin phototype IV-VI were enrolled. Subjects were irradiated on their back with VL using two light sources: one containing pure VL and one containing VL with less than 0·5% UVA1 (VL+UVA1). Four different irradiances were administered to investigate reciprocity behaviour. Assessments, including photography, Investigator's Global Assessment, colorimetry and spectroscopy, were performed immediately, 24 h, 7 days and 14 days post-irradiation. RESULTS: Pigmentation was observed with both light sources; however, pigment intensity was greater with VL+UVA1 than with pure VL. Reciprocity was observed in pure VL sites, but not VL+UVA1. Variation in spectral output had greater impact on pigment intensity than irradiance. Clinical erythema was observed on the VL+UVA1 side, but not on the pure VL side. A protocol for testing photoprotection product efficacy against VL-induced effects has been proposed. CONCLUSIONS: The findings suggest a synergistic relationship between VL and UVA1 and emphasize the need for developing means of photoprotection against VL.


Asunto(s)
Eritema/etiología , Luz/efectos adversos , Pigmentación de la Piel/efectos de la radiación , Dorso , Femenino , Humanos , Masculino , Rayos Ultravioleta/efectos adversos
11.
J Eur Acad Dermatol Venereol ; 32(11): 1879-1886, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29888465

RESUMEN

Photodermatoses represent a heterogeneous collection of disorders unified by the characteristic of being provoked through exposure to ultraviolet radiation. Generally, these conditions are classified into the following categories: immunologically mediated photodermatoses, chemical- and drug-induced photosensitivity, photoaggravated dermatoses and photosensitivity associated with defective DNA repair mechanisms or chromosomal instabilities. The list of photodermatoses is extensive, and each individual photodermatosis is understood to a different extent. Regardless, there exists a paucity of information with regards to the clinical presentation among those with skin of colour. With ever-changing global demographics, recognition of photosensitive disorders in a diverse population is essential for accurate diagnoses and therapeutic guidance. The scope of this article seeks to review the epidemiology and clinical variability in presentation of such photodermatoses in patients with skin of colour.


Asunto(s)
Dermatitis Fotoalérgica/diagnóstico , Dermatitis Fototóxica/diagnóstico , Pigmentación de la Piel/fisiología , Luz Solar/efectos adversos , Rayos Ultravioleta/efectos adversos , Dermatitis Fotoalérgica/epidemiología , Dermatitis Fotoalérgica/patología , Dermatitis Fototóxica/epidemiología , Dermatitis Fototóxica/patología , Femenino , Humanos , Masculino , Trastornos por Fotosensibilidad/diagnóstico , Trastornos por Fotosensibilidad/epidemiología , Trastornos por Fotosensibilidad/patología , Examen Físico/métodos , Prevalencia , Pronóstico , Medición de Riesgo
13.
Br J Dermatol ; 174(4): 862-8, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26663029

RESUMEN

BACKGROUND: Acne vulgaris is a common condition that occurs in all skin types. Postinflammatory hyperpigmentation (PIH) is often associated with acne in patients of darker skin types, making it a common complaint in dermatology offices. Despite this, there is limited understanding of and effective treatment options for PIH. OBJECTIVES: The study objective was to validate an in vivo model for PIH and to compare the clinical, histological and spectroscopic characteristics of artificially induced PIH and acne-induced PIH. METHODS: A nonblinded, nonrandomized pilot study was performed. Thirty subjects served as their own control in which four sites treated with 35% trichloroacetic acid (TCA) solution and four truncal acne pustules were followed for 8 weeks and were evaluated clinically and histologically, and by colorimetry and spectroscopy. RESULTS: The initial phases of inflammation between TCA- and acne-induced PIH differ. However, clinical evaluations were similar on and after day 14. Acne- and TCA-induced lesions were clinically, histologically and spectroscopically indistinguishable at day 28. CONCLUSIONS: Clinical, spectroscopic and histological similarities of acne-induced and TCA-induced PIH at day 28 suggest that TCA-induced PIH can be a reproducible model for the study of acne-induced PIH.


Asunto(s)
Acné Vulgar/patología , Hiperpigmentación/patología , Modelos Biológicos , Adolescente , Adulto , Estudios de Casos y Controles , Cáusticos/toxicidad , Colorimetría , Eritema/inducido químicamente , Eritema/patología , Humanos , Hiperpigmentación/inducido químicamente , Persona de Mediana Edad , Proyectos Piloto , Análisis Espectral , Ácido Tricloroacético/toxicidad , Adulto Joven
15.
Eur J Gynaecol Oncol ; 37(6): 876-881, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-29943942

RESUMEN

Uterine sarcomas have rarely been diagnosed after uterine artery embolization. It remains unclear whether the diagnostic work-up is required prior to such embolization to prevent a missed diagnosis of sarcomas and a delay in providing definitive treatment. Because of the rarity and heterogeneity of endometrial stromal neoplasms, little is known about their epidemiology, pathogenesis, and molecular pathology. The authors report a case of low-grade endometrial stromal sarcoma (ESS) diagnosed after uterine fibroid embolization. Although they performed laparoscopic biopsy of the rapidly growing uterine mass, they could not detect the ESS. Although rare, ESS should be considered in the differential diagnosis of uterine fibroid enlargement. It is essential to assess the risk of malignancy by taking into account the patient's clinical symptoms, results of the physical exam, and imaging findings prior to uterine artery embolization. Pathologic diagnosis should include an adequate biopsy sample and the use of molecular genetic testing.


Asunto(s)
Adenomiosis/terapia , Embolización Terapéutica , Neoplasias Endometriales/diagnóstico , Tumores Estromáticos Endometriales/diagnóstico , Leiomioma/terapia , Neoplasias Uterinas/cirugía , Adulto , Neoplasias Endometriales/patología , Tumores Estromáticos Endometriales/patología , Femenino , Humanos
16.
J Eur Acad Dermatol Venereol ; 29(11): 2069-79, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26370093

RESUMEN

BACKGROUND: Actinic keratosis (AK) is a frequent health condition attributable to chronic exposure to ultraviolet radiation. Several treatment options are available and evidence based guidelines are missing. OBJECTIVES: The goal of these evidence- and consensus-based guidelines was the development of treatment recommendations appropriate for different subgroups of patients presenting with AK. A secondary aim of these guidelines was the implementation of knowledge relating to the clinical background of AK, including consensus-based recommendations for the histopathological definition, diagnosis and the assessment of patients. METHODS: The guidelines development followed a pre-defined and structured process. For the underlying systematic literature review of interventions for AK, the methodology suggested by the Cochrane Handbook for Systematic Reviews of Interventions, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was adapted. All recommendations were consented during a consensus conference using a formal consensus methodology. Strength of recommendations was expressed based on the GRADE approach. If expert opinion without external evidence was incorporated into the reasoning for making a certain recommendation, the rationale was provided. The Guidelines underwent open public review and approval by the commissioning societies. RESULTS: Various interventions for the treatment of AK have been assessed for their efficacy. The consenting procedure led to a treatment algorithm as shown in the guidelines document. Based on expert consensus, the present guidelines present recommendations on the classification of patients, diagnosis and histopathological definition of AK. Details on the methods and results of the systematic literature review and guideline development process have been published separately. CONCLUSIONS: International guidelines are intended to be adapted to national or regional circumstances (regulatory approval, availability and reimbursement of treatments).


Asunto(s)
Queratosis Actínica/terapia , Terapia Combinada , Medicina Basada en la Evidencia , Humanos , Queratosis Actínica/diagnóstico , Queratosis Actínica/etiología
18.
19.
J Dermatol ; 51(7): 1004-1009, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38700256

RESUMEN

The objective of our study was to assess the attitudes and behaviors in Japan regarding sun exposure and compare them to those in Europe and North America. The study population was a representative sample of individuals aged >18 years from Ipsos panels in Japan (N = 1000), North America (N = 1000), and Europe (N = 6000) using the quota method. Questionnaires covered habits, practices, and perceptions regarding sun exposure. Results revealed that the majority of people (80.1%) believed that the sun gives them energy, and 61.1% considered that being tanned made them look healthier. However, there was a significant difference between men and women regarding the appeal of tanned skin, with 54.95% of men versus 34.67% (p < 0.001) of women seeing a tan as an aesthetic asset. People aged <40 years were less likely to find a tan attractive (30.3%) compared to those aged ≥40 years (48.9%) (p < 0.001). Of those questioned, 45.70% of used sunscreen with a much higher use among women (70.10%) than men (18.74%) (p < 0.001). Almost 54% of people said they stayed in the shade to protect themselves from the sun with this behavior being more prevalent among women (67.05%) and fair-skinned individuals (56.13%). Fear of the risks of sun exposure was more common among women, with 84.8% fearing premature skin aging, compared to 71.8% of men (p < 0.001). In Japan, 44.30% of those questioned said tanned skin was attractive (p < 0.001); for Europeans and North Americans the proportions were 81.1% and 77.6%, respectively. Only a quarter (25.80%) thought it essential to return from vacation with a tan. On the other hand, Europeans showed a strong recognition of the energy the sun brings (83.18%), and widely believed that tanned skin is attractive (82.32%) and healthy (73.15%). In North America, attitudes were similar to those in Europe regarding the attractiveness of tanned skin (77.65%) and the importance of returning tanned from vacation (48.15%). Compared to Europeans and North Americans, the Japanese seemed to be more cautious about sun-induced hazards and considered lighter skin to be more attractive.


Asunto(s)
Conocimientos, Actitudes y Práctica en Salud , Luz Solar , Protectores Solares , Humanos , Femenino , Masculino , Adulto , Japón/epidemiología , Europa (Continente) , América del Norte/epidemiología , Persona de Mediana Edad , Luz Solar/efectos adversos , Protectores Solares/administración & dosificación , Encuestas y Cuestionarios , Adulto Joven , Baño de Sol/estadística & datos numéricos , Baño de Sol/psicología , Adolescente , Anciano , Factores Sexuales , Conductas Relacionadas con la Salud
20.
Br J Dermatol ; 179(5): 1019-1020, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30387510
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA